Menu

Image of the Day: Hot Pink Squirrels

Under UV light, flying squirrels give off a rosy glow.

Feb 15, 2019
Carolyn Wilke

ABOVE: Flying squirrel at a feeder under UV light
JON MARTIN

Ultraviolet light imbues some flying squirrels with pink hues, according to a study published January 23 in the Journal of Mammology. Researchers studied several species of flying squirrels, flashing both animals from the wild and museum specimens with UV light to see if they fluoresce. Of North and Central American squirrels, males and females alike of all three extant species appeared in a range of rosy tones.

The flying squirrel joins the ranks of other UV fluorescent animals that emit visible light, including several birds, reptiles, amphibians, and marsupials. Why hot pink for flying squirrels? That is yet unknown. 

A flying squirrel viewed under visible light (left) and fluorescing pink under UV (right)
PHOTO COURTESY OF KOHLER ET AL.

A.M. Kohler et al., “Ultraviolet fluorescence discovered in New World flying squirrels (Glaucomys),” Journal of Mammology, doi:10.1093/jmammal/gyy177, 2019.

March 2019

Going Under

Dissecting the effects of anesthetics

Marketplace

Sponsored Product Updates

The Complex Biology of Macrophages: Origins, Functions, and Activation States
The Complex Biology of Macrophages: Origins, Functions, and Activation States
Download this poster from R&D Systems for a detailed overview of macrophage markers, functions, development, specialization, and activation!
A Guide to Measuring Drug-Target Residence Times with Biochemical Assays
A Guide to Measuring Drug-Target Residence Times with Biochemical Assays
Download this guide from BellBrook Labs to learn about how to use Transcreener® biochemical assays to measure drug-target residence times, complete with examples and case studies!
Beckman Coulter Life Sciences To Launch New Product Via Live Stream Event
Beckman Coulter Life Sciences To Launch New Product Via Live Stream Event
After visiting labs around the world to identify ways to advance its industry-leading cell counting technology, Beckman Coulter Life Sciences will host a live streaming event on March 26 at 10 a.m. EDT / 7 a.m. PDT to announce its latest product innovation.  
Cybrexa Therapeutics to Present First Data and Unveil Details for its alphalex™-PARP Inhibitor Lead Candidate CBX-11 at AACR Annual Meeting 2019
Cybrexa Therapeutics to Present First Data and Unveil Details for its alphalex™-PARP Inhibitor Lead Candidate CBX-11 at AACR Annual Meeting 2019
Cybrexa Therapeutics, a biotechnology company developing a new class of cancer therapeutics through its alphalex™ tumor targeting platform, today announced that Vishwas Paralkar, PhD, Chief Scientific Officer of Cybrexa, will present the first set of preclinical data supporting its alphalex™-PARP inhibitor lead candidate, CBX-11, at the American Association for Cancer Research (AACR) Annual Meeting 2019, being held March 29 – April 3 in Atlanta, Georgia. At the meeting, the Company will unveil the FDA-approved poly ADP-ribose polymerase (PARP) inhibitor conjugated in CBX-11.